Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Aveo receives milestone payment from Biogen Idec for erbB-3 antibody program

April 16, 2010

Companies invest in Avraham to pursue phase IIb ladostigil trial in Alzheimer's disease

April 16, 2010

Cyplasin signs term sheet with vaccine company to license AAD technology

April 16, 2010

Swedish Orphan Biovitrum receives distribution rights to Rhucin in agreement with Pharming

April 16, 2010

Metabolex and Takeda enter research collaboration for biological products

April 15, 2010

Catalyst signs agreement with NIDA for phase IIb vigabatrin trial for cocaine addiction

April 15, 2010

RXi and miRagen to collaborate on miRNA-based agents

April 15, 2010

Proximagen grants Upsher-Smith rights to tonabersat for epilepsy in North America

April 15, 2010

Sanofi Pasteur and U.S. Naval Medicine Center partner to develop travelers' diarrhea vaccine

April 14, 2010

RXi and Mirna Therapeutics form microRNA research collaboration

April 14, 2010

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...